Some of the T cell epitopes targeting myelin in monkeys were the same as those found in humans. Researchers say linking these specific cells opens the doors to developing antiviral therapies that could be useful to treat newly diagnosed cases of MS in …
Article Correctness Is Author's Responsibility: Gut Immune Cells May Help Send Multiple Sclerosis Into Remission
Study finds signs of IgA antibodies in the cerebrospinal fluid of patients with multiple sclerosis during a flare-up of the disease, but not when the patients are in remission. The findings suggest gut immune cells are involved in relapse episodes of m…
Article Correctness Is Author's Responsibility: Study Explores Sleep Apnea, Autoimmune Disease Link
Poor sleep and inadequate oxygen supply associated with obstructive sleep apnea appears to affect cytokines. This could explain the link between OSA and an increased risk of autoimmune disorders, such as rheumatoid arthritis.
Article Correctness Is Author's Responsibility: Promising Multiple Sclerosis Drug Could Worsen Disease
TEPP-46, a drug developed for the treatment of cancer and showed promise for the treatment of multiple sclerosis, could make MS symptoms worse, a new study reports. The drug appears to redirect inflammation away from the spinal cord and directly into t…
Article Correctness Is Author's Responsibility: Anti-Inflammatory Therapy Shows Promise in Slowing Progression of Multiple Sclerosis
A new intranasal delivery system shows promise in reducing neuroinflammation and slowing the progression of multiple sclerosis.
Article Correctness Is Author's Responsibility: New Therapy Improves Treatment for Multiple Sclerosis
By fusing a cytokine to a blood protein, researchers have developed a new therapy to help treat multiple sclerosis.
Article Correctness Is Author's Responsibility: Immune System May Have Another Job, Combatting Depression
Gamma interferons, a type of immune cell that induces and modulates several immune system responses, may also play a role in preventing depression.
Article Correctness Is Author's Responsibility: Pregnancy Can Delay Onset of Multiple Sclerosis Symptoms by Three Years
Women who have been pregnant were diagnosed with their first multiple sclerosis symptoms, on average, 3.3 years later than women with MS who had never become pregnant.
Article Correctness Is Author's Responsibility: Tag Team Gut Bacteria Worsen Symptoms of Multiple Sclerosis
Specific combinations of microorganisms in the gut can worsen symptoms of multiple sclerosis in mouse models of the autoimmune disease.
Article Correctness Is Author's Responsibility: ‘Reelin’ in a New Treatment for Multiple Sclerosis
Decreasing the amount of Reelin significantly protected against disease symptoms and promoted recovery in symptomatic animal models of multiple sclerosis. Reelin levels appear to correlate with MS severity and stages. Researchers report lowering levels…
Article Correctness Is Author's Responsibility: Animal study shows human brain cells repair damage in multiple sclerosis
Human iPSCs transplanted into animal models of multiple sclerosis help repair cell damage and restore function.
Article Correctness Is Author's Responsibility: Researchers pinpoint genes behind sex biases in autoimmune disorders and schizophrenia
A new study reveals why women are more likely to develop autoimmune conditions like lupus and Sjögren’s syndrome, and men are more likely to develop schizophrenia. Researchers implicated the C4 gene in sex-based risk factors for autoimmune and psychiat…
Article Correctness Is Author's Responsibility: Further evidence autoimmunity plays a role in Parkinson’s disease
T cells that react to alpha-synuclein are most abundant in the early stages of Parkinson’s disease but tend to disappear as the disease progresses. Signs of autoimmunity can appear in Parkinson’s patients up to ten years before a diagnosis of the neuro…
Article Correctness Is Author's Responsibility: Compound in fruit peels halts damage and spurs neuronal repair in multiple sclerosis
Ursolic acid, a compound abundant in fruit peels and some herbs, appears to decrease further neural damage and help regenerate myelin in mouse models of multiple sclerosis. Study reveals ursolic acid suppresses TH17 cells, which are one of the main dri…
Article Correctness Is Author's Responsibility: FDA approves ozanimod for treatment of multiple sclerosis
The FDA has approved a new drug named Ozanimod for the treatment of multiple sclerosis. Ozanimod binds to receptors in lymphocytes’ surfaces, preventing them from reaching the brain. As the number of active lymphocytes decreases, the attack on the immu…
